The emergence of mixed speciality oncology
The increased use of targeted therapies in oncology has introduced a range of new side effects. Emma Foreman, BPharma (Hons) of The Royal Marsden NHS Foundation Trust, London, UK, discusses how these ...
Author: VJOncology
Added: 10/15/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Foundation Trusts